The exploding politics of biotechnology.
By one o'clock Wednesday morning, Democrats had taken the lead in the U.S. Senate races in Virginia and Montana. Control of the Senate came down to Missouri, where Democrat Claire McCaskill trailed Jim Talent, the Republican incumbent, with three-quarters of the ballots counted. In a final surge, McCaskill took the race and the Senate. And with her came the political issue of the future: biotechnology.
Until now, elections have focused on three kinds of issues. During the Cold War, national security vied with economics. Cultural issues came third. Then Communism collapsed, and we crushed Iraq in the Gulf War. Military and foreign policy lost their urgency, and a recession dominated the 1992 presidential campaign. "It's the economy, stupid," argued strategists for the governor of Arkansas. So we put him in the White House.
As the economy improved, that issue, too, lost urgency. Cultural debates took over. Guns helped the GOP capture Congress in 1994. Conservatives developed two new wedge issues: gay marriage and partial-birth abortion. No piety seemed too small. A presidential campaign about V-chips and school uniforms was followed by an impeachment for covering up an affair. The governor of Texas stumbled through a debate on foreign policy but promised to uphold the honor of the presidency, which everyone understood to mean his pants.
On Sept. 11, 2001, the vacation from national security ended. President Bush declared a war on terror. Republicans won the 2002 elections by accusing Democrats, falsely, of opposing a department of homeland security. In 2004, they swift-boated John Kerry and skewered him for voting against war appropriations. This week, with Iraq in disarray and troop fatalities mounting, voters threw the GOP out. They didn't care that unemployment had just hit a five-year low. When the question is your money or your life, life wins.
Which brings us to Missouri. There, the usual issues canceled each other out. On balance, people who worried about terrorism voted for Talent; voters who worried about Iraq voted for McCaskill. Those concerned about the economy backed McCaskill; those concerned about values backed Talent. But one more issue was in the mix this year: a ballot measure to prevent restrictions on embryonic stem-cell (ESC) research. McCaskill endorsed the measure, known as Amendment 2, and supported federal funding of the research. Talent opposed both.
Proponents of Amendment 2 framed it as a life-or-death issue, like war. They called themselves the Missouri Coalition for Lifesaving Cures. All of their television ads ended with the words, "It could save the life of someone you love." They argued that ESC research might help cure or treat a host of ills, including Parkinson's, diabetes, spinal-cord injuries, severe burns, multiple sclerosis, cancer, and Alzheimer's.
Opponents assailed Amendment 2 as a threat to human dignity. They said it would "redefine human life," protect "human cloning for research," promote "creating human life in the laboratory," and spawn "a mini-Gold Rush in human tissue," with demand for "millions of human eggs."
Both sides twisted the truth. ESC research hasn't cured anything, and Amendment 2 doesn't fund it. But each side's warning was essentially true. If you block ESC research, you're closing off what might be the quickest path to saving many lives. And if you promote the research, along with the embryonic cloning that makes it therapeutically useful, you're seriously messing with the foundations of life. You're creating artificial human entities. You're turning eggs and embryos into medical supplies.
These two truths aren't going away. The life-saving potential of biological research will only increase its political power. The baby boomers are turning 60. They'll reach for any technology that offers hope of staving off illness and death. So will the generations behind them.
Meanwhile, the technology grows more complicated. Stem cells from leftover embryos are only the beginning. To cure people reliably, you have to move on to cloning. To avoid cloning, you have to devise alternatives, such as reprogramming adult cells, which might enable any cell in your body to become an embryo. To eradicate diseases with today's technology, you'd have to screen embryos and flush the ones with bad genes. With tomorrow's technology, you'll be able to re-engineer them. Each of these advances saves life at the price of dissolving it. We're taking ourselves apart.
Will Saletan covers science, technology, and politics for Slate and says a lot of things that get him in trouble.
Photograph of test tubes on Slate's home page by Getty Images.